Squamous Cell Carcinoma of the Head and Neck
3 competing products in clinical development for Squamous Cell Carcinoma of the Head and Neck.
Pipeline by Phase
Phase 11
Phase 32
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nivolumab + Cetuximab + Methotrexate + Docetaxel | Ono Pharmaceutical | Phase 3 | Completed | 40 |
| Nivolumab + Cetuximab + Cisplatin | Ono Pharmaceutical | Phase 3 | Completed | 40 |
| Patritumab + Cetuximab + Cisplatin + Carboplatin | Daiichi Sankyo | Phase 1 | Completed | 29 |